Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of Apify and ManageEngine RecoveryManager Plus — release velocity, themes, recent moves, and the top alternatives to consider.
| Feature | Apify | ManageEngine RecoveryManager Plus |
|---|---|---|
| Sector | Analytics | Analytics |
| Velocity score | 7.5 | 2.5 |
| Sparks · 30d | 1 | 0 |
| Top themes | web-scraping, ai-agents, mcp, agentic-payments | ad-backup, entra-id, disaster-recovery, cloud-storage |
| Last editorial update | 27d ago | 1h ago |
| Website | — | Visit → |
Apify rebuilds its scraping platform around AI agents as the primary user
Apify runs a marketplace of "Actors" (hosted scrapers and automations). Its recent releases treat AI agents, not just human developers, as the primary consumer: an agentic payment rail, MCP connectors, an MCP configurator, and now a natural-language interface that picks and runs the right Actor for you. The classic browse-compare-configure flow is being demoted in favor of intent.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
Read the full ManageEngine RecoveryManager Plus trajectory →
Apify runs a marketplace of "Actors" (hosted scrapers and automations). Its recent releases treat AI agents, not just human developers, as the primary consumer: an agentic payment rail, MCP connectors, an MCP configurator, and now a natural-language interface that picks and runs the right Actor for you. The classic browse-compare-configure flow is being demoted in favor of intent.
Every major move points the same way: make Actors callable, payable, and discoverable by autonomous agents. x402 lets agents pay per run in USDC with no account; MCP connectors let Actors reach login-gated apps without seeing credentials; task publishing and the guided creation flow feed the discovery surface that agents read. Apify is positioning as data infrastructure for the agent economy.
Expect Apify AI to move from beta toward the default entry point on Store and in the Dashboard, and for agentic payments and MCP to be knit together so an agent can discover, run, and pay for an Actor end to end. The entries support that convergence without needing outside facts.
RecoveryManager Plus is a backup-and-recovery tool for Active Directory and Microsoft 365, and it is the most feature-active of the ManageEngine set here. Recent builds add real backup coverage — AD sites and subnets, Entra ID local admin passwords, S3-compatible repositories, SIEM audit forwarding, and Entra ID BitLocker recovery keys — alongside CVE patches and RemCom agent hardening. Build 6322 is the quietest of the run: a single fix for restarts triggered by an outdated ExchangeOnlineManagement PowerShell module during Microsoft 365 enumeration.
The direction is coverage expansion: methodically extending what can be backed up and restored across on-prem AD and Entra ID, while broadening cloud storage targets and operational integrations. The dependence on Microsoft's own PowerShell modules is the cost of that coverage, and 6322 shows where it bites — a stale module on the customer's side takes the product down mid-enumeration. Feature builds and pure-fix builds alternate at roughly a two-month cadence, so a single-issue build reads as a gap between feature cycles rather than a slowdown.
Expect continued expansion of Entra ID and cloud-native backup coverage and more storage-target options, with security patches folded into each build; the next build carrying a Features section is due on the cadence this feed has held.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Apify or ManageEngine RecoveryManager Plus.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all Apify alternatives → · See all ManageEngine RecoveryManager Plus alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Apify is currently shipping more aggressively (velocity 7.5 vs 2.5), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Apify is currently shipping more aggressively (velocity 7.5 vs 2.5), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top Apify alternatives in Analytics are ranked by recent ship velocity. Browse the "Apify alternatives" section above for the current picks, or visit /alternatives/apify for the full list with editorial commentary on each.
Top ManageEngine RecoveryManager Plus alternatives in Analytics are ranked by recent ship velocity. Browse the "ManageEngine RecoveryManager Plus alternatives" section above for the current picks, or visit /alternatives/manageengine-recoverymanager-plus for the full list with editorial commentary on each.